Tinabinol
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
|
|
CAS Number | 50708-95-7 |
PubChem (CID) | 65443 |
ChemSpider | 58905 |
Chemical and physical data | |
Formula | C23H34O2S |
Molar mass | 374.580 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol which was patented as an antihypertensive but was never marketed.[1][2]
See also[edit]
References[edit]
- ^ David T. Brown (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
- ^ Martin Negwer (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.
Receptor (ligands) |
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
|
||||||||||||||||||
Enzyme (modulators) |
|
||||||||||||||||||
Others |
|
||||||||||||||||||
|
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Tinabinol&oldid=745261321"